ACE-inhibitors associated with lower COVID-19 severity

ACE-inhibitors associated with lower COVID-19 severity

Contrary to the initial hypothesis that ACE-inhibitors may increase the risk of severe COVID-19 infection, a small study with a cohort of 205 acute COVID-19 patients was shown to be associated with lower severity of COVID-19 and outcomes, reports a pre-print, non-peer-reviewed article published on medrxiv, titled, 'Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust'.

https://doi.org/10.1101/2020.04.07.20056788
Full PDF


Share Tweet Send
0 Comments
Loading...
You've successfully subscribed to COVID-19
Great! Next, complete checkout for full access to COVID-19
Welcome back! You've successfully signed in
Success! Your account is fully activated, you now have access to all content.